CE19 - Technologies pour la santé 2022

Non-invasive longitudinal analysis of VOCAL fold functIon based on simultaneous translaryngeal ultraSound and voicE acquisitions – VOCALISE

Submission summary

Dynamic translaryngeal ultrasound (dTLUS), a non-invasive and inexpensive technique, has emerged in recent years as an alternative to nasofibroscopy, a minimally invasive method to assess vocal cord paralysis. This paralysis is the major risk (occurrence of 3 to 5%) associated with cervical surgery (100 000 procedures per year in France). The first works of our consortium have shown the performances of dTLUS after thyroid or parathyroid surgery, to diagnose early the paralysis of one of the vocal cords.
The objective of VOCALISE is to propose a new approach allowing a better characterization of postoperative or radiation-induced dysphonia. It consists in associating to the dTLUS optimized acquisitions of the vibration of each vocal cord during phonation simultaneously with voice/speech recordings. A software for the analysis of the displacement of the arytenoids, surrogate markers of the vocal cords, will be developed to finely quantify the mobility of the laryngeal structures, by combining classical methods of motion analysis and deep learning methods.
This approach will be evaluated: 1) to monitor speech therapy in patients with recurrent nerve injury and 2) to qualify radiation-induced dysphonia in patients with Head and Neck cancers treated with radiotherapy.
For this project, three academic partners with complementary skills who have been collaborating for several years have joined forces with two industrial partners: Mindray Medical France and Apteryx. Mindray will develop an acquisition module dedicated to the functional study of vocal folds. Apteryx will develop a software to quantify the movement of laryngeal structures. This software will also allow the follow-up and the optimization of the management of patients with dysphonia.

Project coordination

Frédérique FROUIN (Laboratoire d'Imagerie Translationnelle en Oncologie-U1288)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

Mindray Medical France SARL
Apteryx
LIB Laboratoire d'Imagerie Biomédicale
LPP Laboratoire de Phonétique et Phonologie
LITO Laboratoire d'Imagerie Translationnelle en Oncologie-U1288
DRCI Direction de la Recherce Cliniquer et de l'Innovation

Help of the ANR 499,495 euros
Beginning and duration of the scientific project: November 2022 - 42 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter